Struma ovarii is a highly specialised form of mature ovarian teratoma. When thyroid tissue constitutes 50% or more of the ovarian neoplasm, the tumour is termed struma ovarii [1] . Malignant struma ovarii is rare and makes up 0.1-0.3% of all ovarian teratomas [2] . We describe a case of follicular variant of papillary carcinoma arising from struma ovarii with elevated CA-125 and pseudo-Meig syndrome.
Case report
A 57-year old postmenopausal woman developed progressive generalised abdominal distension over three months. She was otherwise asymptomatic. Her medical and family history was unremarkable and there was no history of thyroid disease. On examination she was found to have gross ascites without any palpable abdominal masses. Vaginal and rectal examinations were normal. No thyroid enlargement was noticed. The CT-scan of the abdomen showed a mixed density illdefined mass in the region of left adnexae with ascites. Her routine blood investigations were normal. Thyroid function tests were not done preoperatively. Her CA-125 level was over 500 u/ml, and chest xray showed a small right-sided pleural effusion.
A provisional diagnosis of ovarian malignancy was made and total abdominal hysterectomy and bilateral salpingo-oophorectomy with omental biopsy was done. Apart from a multilocular left ovarian tumour and ascites no abnormalities were seen in the abdominal cavity.
Histological examination revealed a multicystic left ovary of 4×5×2 cm composed mainly of thyroid tissue. A small focus of thyroid carcinoma (3mm) composed of follicles lined by overlapping optically clear nuclei was present. No papillae were noticed within the malignant component and mature cartilage was found within the ovary. A pathological diagnosis of follicular variant of papillary carcinoma was made. The right ovary showed mature cystic teratomas. Uterus, cervix, tubes and omental tissue did not reveal any pathological changes. Ascitic fluid was free of tumour cells.
Total thyroidectomy followed by 131 I ablation is the recommended treatment for malignant stuma ovarii. However, we decided to manage this patient conservatively considering the small size of the malignant tumour. Thyroid function tests, chest xray, ultrasound abdomen and CA-125 (7u/ml) one month after surgery were normal.
Discussion
Struma ovarii has elicited considerable interest among gynaecologists because of its many fascinating features. Its atypical presentation can rarely mimic a typical ovarian carcinoma. Many cases of stuma ovarii have been reported with elevated CA-125 level, ascites and hydrothorax (pseudo-Meig syndrome) [3, 4, 5, 6, 7, 8] . Only one case has shown malignant thyroid tissue and it has been reported as the first malignant struma ovarii patient with pseudo-Meig syndrome and elevated CA-125 [5] .
The current criteria for pathological diagnosis of malignant struma ovarii include the same histological features used for the diagnosis of thyroid carcinoma such as "overlapping ground-glass nuclei" [1] .The patient we describe also showed the typical groundglass histological pattern without papillary features, finally diagnosed as a follicular variant of papillary carcinoma.
Because of its rarity there was no consensus on the management of malignant struma ovarii. These patients have traditionally been treated with total abdominal hysterectomy and bilateral oophorectomy as for any other ovarian tumour. Thyroidectomy and 131 I therapy have been given only if metastases or recurrence is detected [2] . These patients should be treated as if they had thyroid carcinoma rather than an ovarian carcinoma [9, 10] . The patients treated conservatively after surgery were found to have higher rates of recurrence compared to those who got 131 I treatment as adjuvant [2, 10] . Accordingly, all patients with malignant stuma ovarii should undergo total thyroidectomy followed by 131 I ablation to prevent relapse.
